In pharma industry takeover of a generic company by a generic company is on the rise. Recently, some generic companies are aquiring other generic companies like Sun pharma trying hard to buy Taro.
Now, the Mister generic of Pharma world Teva Pharma (as declared by Teva's Chief Executive Shlomo Yanai Here) in a bid to aquire generic firms have paid $400 million to buy CoGenesys and is expected to close soon on a deal to purchase Bentley Pharmaceuticals for about $350 million. Now an Israeli news paper has speculated here that Teva will buy Barr Pharma for about 7-7.5 billion dollars
Barr is one of the frontier generic company with more than 100 approvals in regulated market and also has First to file 180 days exclusivity on some molecules in US market, so deal will be quite useful for Teva. In the past, both generic companies have shared 180 days exclusivity on some molecules in US market like in case of Fexofenadine and Alendronate.
No comments:
Post a Comment